TriGUARD™ 3 Device
CAUTION – The TriGUARD 3™ Cerebral Protection Device is not commercially available. An investigational device for investigational use only.
Practical Considerations and Design Requirements for Clinically Relevant CEP: The Keystone TriGUARD3 Device
Tamim Nazif, MD
Building the Evidence for CEP in TAVR: A Critical Review of the Clinical Trial Data
Jeffrey W. Moses, MD
ProtectionThe Search for Meaningful Measures of ClincialEfficacy: NeuroARCand Beyond
Alexandra Lansky, MD
A critical review of the neurological effects of invasive cardiac procedures
Pieter Stella, MD, PhD
The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR
Samir Kapadia, MD
TriGUARD3 Procedure Animation
TCT 2017 Keystone Heart Symposium
TriGuard™ Device
Mitigating Stroke Risk in TAVR: Important Considerations as TAVR Moves to Lower-Risk Patients
Dr. Benjamin Z. Galper, MD, MPH
The Spectrum of Neurologic Events after TAVR: Insights from NueroARC
Dr. Alexandra Lansky, MD
TriGuard™ Device for Cerebral Embolic Protection During TAVR: A Multicenter Real World Experience
Dr. Alexandra Lansky, MD
Cerebrovascular Complications after Valve Intervention: Incidence and New Standardized Definitions on behalf of NeuroARC
Dr. Alexandra Lansky, MD
Keystone Heart, LTD. featured on Worldwide Business with kathy ireland®
Embolic Protection Webcast – TCT 2016
Breaking News: Cerebral Embolic Protection Device
TriGuard™: The ONLY Cerebral Protection Device to Cover All Aortic Arch Takeoffs (A Procedure Animation)
Professor Stella, UMC Utrecht, NL
A Message from Dr. Raj Makkar, the Co-PI of the REFLECT Study
Dr. Raj Makkar
What You Need to Know About Cerebral Embolic Protection (CEP): The Need for CEP
Dr. Martin B. Leon, MD
Update on Clinical Evidence to Support Cerebral Embolic Protection (CEP) During TAVR
Dr. Jeffrey W. Moses, MD
Economic Impact of Cerebral Embolic Protection: Important Considerations as TAVR Moves to Lower-Risk Patients
Dr. Hemal Gada, MD, MBA
Meaningful End-Points of CEP Clinical Trials to Support Adoptions – Major Stroke, Minor Stroke, Imaging?
Dr. Rahul Sharma, MD
Diagnostic Considerations and NeuroARC
Dr. Alexandra Lansky, MD
TVT 2017 Keystone Heart Presentations
Drs. Leon, Moses, Gada, Sharma, Lansky